Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Diabetes Metab Syndr ; 13(1): 312-316, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30641718

RESUMO

BACKGROUND: Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a serine protease and a secreted protein which increases cholesterol levels in plasma via inducing degradation of low-density lipoprotein receptor (LDLR). Cluster of differentiation 36 (CD36) is a member of a family of cell surface proteins in many cells. CD36 is known as fatty acid translocase (FAT) because it imports fatty acids inside cells and participate in triglyceride storage. It has been suggested that PCSK9 regulates CD36 in some tissues. METHODS: Data and serum levels of TSH, FT4, lipid profile and PCSK9 and the expression of CD36 on monocytes from 40 new untreated patients with subclinical hypothyroidism (SH) and 40 age- sex- and BMI-matched euthyroid controls were analyzed in a cross-sectional study. Then the relationships between these parameters were examined. RESULTS: Patients with SH had higher TSH, FT4, total cholesterol (TC) and triglyceride (TG) Low-density lipoprotein (LDL) and PCSK9 levels than controls. There were significant and positive correlations between serum TSH levels and lipid parameters except HDL-C. PCSK9 had a significant and negative correlation with FT4. No significant correlation could be found in relation to PCSK9 and CD36. CONCLUSIONS: PCSK9 inhibitors are used to reduce blood cholesterol levels as drugs. If it will be proven that PCSK9 can induce CD36 degradation, taking these drugs may have unwanted side effects. This study showed that serum PCSK9 and lipid profile levels increase in patients with subclinical hypothyroidism and there is no relationship between PCSK9 and CD36 in these patients.


Assuntos
Biomarcadores/sangue , Antígenos CD36/sangue , Colesterol/sangue , Hipotireoidismo/sangue , Lipídeos/sangue , Monócitos/metabolismo , Pró-Proteína Convertase 9/sangue , Adolescente , Adulto , Estudos de Casos e Controles , Estudos Transversais , Feminino , Seguimentos , Humanos , Hipotireoidismo/patologia , Masculino , Pessoa de Meia-Idade , Monócitos/patologia , Prognóstico , Receptores de LDL/sangue , Adulto Jovem
2.
Int J Biol Macromol ; 123: 682-690, 2019 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-30447374

RESUMO

The aim of this study was to improvement of adsorption capacity of porous starch (PS) by incorporation of halloysite nanotube (HNT). PS/HNT carrier was synthesized through the solvent exchange method. Various fabrication approaches for PS were introduced and different ethanol ratio (40, 60, 80, 100%), HNT concentration (0, 0.1, 0.2, 0.3, 0.4 and 0.5 mg/mL) and drying method (oven, freeze dryer and microwave) were applied. The results indicated that high ratio of ethanol created larger pores and also the best results were obtained from freeze-dried samples (p < 0.05). Incorporation of HNT could further improve the adsorption capacity. However, the best oil and water adsorption capacity were related to PS alone. The nitrogen adsorption-desorption measurement and scanning electron microscopy elucidated the porous structure of samples. The experimental data were fitted successfully by the Langmuir model rather than Freundlich isotherm. Also PS/HNT had higher apparent density and more negative zeta potential rather than PS. However, the DSC results showed the similar thermal patterns for PS and PS/HNT.


Assuntos
Argila/química , Nanotubos/química , Amido/química , Adsorção , Silicatos de Alumínio/química , Microscopia Eletrônica de Varredura , Porosidade , Solventes/química , Termodinâmica , Água/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...